LLY240705C960000
- 0.45
- -0.31-40.79%
Eli Lilly and Co Newsroom
Eli Lilly & Co (NYSE:LLY): Jim Cramer's Best Weight Loss Stock Pick for 2024
Social Buzz: Wallstreetbets Stocks Mixed Premarket Monday; Tesla to Advance, Nvidia to Decline
The most-talked-about stocks in the Reddit subforum Wallstreetbets were mixed hours before Monday's opening bell. Tesla (TSLA) rose by 1.6% in premarket activity, after a 0.2% increase from the previo
US drug prices have skyrocketed by 40%! Over 30% of people are 'hopeless sighs' about the high cost of drugs, and Biden is urgently pushing measures to address it.
In the past decade, prescription drug prices in the USA have skyrocketed by nearly 40%, far exceeding inflation rates, resulting in about one-third of Americans being unable to purchase medicine from pharmacies.
Alnylam, Lilly, AstraZeneca Among Best Performing Pharmas, Biotechs in Q2
Rising Drug Costs Force a Third of Americans to Leave Prescriptions Unfilled: Report
Insulet Tops S&P 500 Growth Chart for Q2 as It Gains Market Share in the Diabetes Space
Cassava Sciences Shares Plunge on Indictment Against Former Advisor -- Barrons.com
By Anita Hamilton A federal indictment of a lead scientist working as an advisor for Cassava Sciences, which has an Alzheimer's drug in late-stage clinical trials, sent shares sharply down Friday. T
Eli Lilly and Company (LLY): A Good Growth Stock To Buy Now According to Billionaire Ray Dalio
Form 144 | Eli Lilly and Co(LLY.US) 10% Stockholder Proposes to Sell 195.44 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 28, $Eli Lilly and Co(LLY.US)$ 10% Stockholder LILLY ENDOWMENT INC intends to sell 215K shares of its common stock on Jun 28, with a total market value of approximately $19
Atossa Therapeutics Doubles Z-Endoxifen Dose in Phase 2 Breast Cancer Study
Atossa Therapeutics (ATOS) said Friday it increased the dose of [Z]-endoxifen to 80 milligrams daily from 40 mg in its phase 2 study of [Z]-endoxifen combined with Eli Lilly's (LLY) abemaciclib in pat
Insights Into Eli Lilly and Co's Performance Versus Peers In Pharmaceuticals Sector
In the fast-paced and highly competitive business world of today, conducting thorough company analysis is essential for investors and industry observers. In this article, we will conduct an extensive
Express News | Atossa Therapeutics: Change in Study Dose Was Determined Following a Review of Safety, Efficacy and Pharmacokinetic (Pk) Data
Dividend Roundup: Kroger, AT&T, Pfizer, JPMorgan, and More
Express News | EMA: Chmp Gave Positive Opinion for Tauvid (Flortaucipir (18F)), for Pet Imaging of the Brain
ResMed Stock Is Down Because of GLP-1 Concerns. It Shouldn't Be. -- Barrons.com
By Jacob Sonenshine Shares of ResMed, a maker of CPAP and other sleep-apnea airway machines, have dropped because of new GLP-1 developments. It's an overreaction -- and the stock is a buy. Shares ar
Him & Hers Down 6% Following Report on 'Shady Supplier' for Weight Loss Drug
Why is Eli Lilly and Co cooperating with OpenAI?
Eli Lilly and Co (LLY.US) is partnering with OpenAI, a ChatGPT manufacturer, to develop new therapies for combating drug-resistant diseases using artificial intelligence (AI).
Zhejiang Int'l Group (000411.SZ) has business collaborations with large pharmaceutical companies including Eli Lilly and Co, Novo-Nordisk A/S.
Zhejiang Int'l Group (000411.SZ) stated on the investor interaction platform on June 27th that the company is a pharmaceutical distribution enterprise mainly engaged in the wholesale and retail business of pharmaceuticals and medical instruments, and has business cooperation with large pharmaceutical enterprises including Eli Lilly and Co and Novo-Nordisk A/S. At present, the company operates tens of thousands of varieties and specifications of pharmaceutical products, including hypoglycemic products, but the sales of specific single variety and specification account for a small proportion of the company's overall sales. The company will continue to pay attention to newly launched drugs and actively carry out relevant introduction work.
Ben & Jerry's Co-Founders Not Worried About Ozempic's Impact On Ice Cream Business: Here's Why
Ben Cohen and Jerry Greenfield, the co-founders of Ben & Jerry's, are not worried about the impact of weight-loss drugs on their ice cream business, despite the impending spin-off of their parent comp
How Consumer Spending, Election Impact Markets: Market Domination
On today's episode of Market Domination, hosts Julie Hyman and Josh Lipton cover how major trends like weak consumer spending and the election are impacting the markets (^DJI, ^IXIC, ^GSPC).